Qingdao Kangyuan Pharmaceutical Co., Ltd
FDA inspection history in Jiaozhou City, China, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Jiaozhou City, China.
Cited most
Across all Qingdao Kangyuan Pharmaceutical Co. observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.160General requirements1
- 21 CFR 211.186Master production and control records1
- 21 CFR 211.194Laboratory records1
- 21 CFR 211.67Equipment cleaning and maintenance1
The complete Qingdao Kangyuan Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Jiaozhou City, China
One Form 483 · 2024
Latest: Form 483, Aug 16, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-08-16 | 483 Form 483 | Jiaozhou City, China | — | $99 |
Investigators on these documents
FEI number 3006512854 · most recent document Aug 16, 2024
About Qingdao Kangyuan Pharmaceutical Co., Ltd
How many FDA Form 483s has Qingdao Kangyuan Pharmaceutical Co., Ltd received?
FDA Intel has 1 Form 483 on file for Qingdao Kangyuan Pharmaceutical Co., Ltd; the most recent is dated Aug 16, 2024.
When was Qingdao Kangyuan Pharmaceutical Co., Ltd last inspected by FDA?
The most recent FDA inspection document on file for Qingdao Kangyuan Pharmaceutical Co., Ltd is a Form 483 dated Aug 16, 2024, for the site in Jiaozhou City, China.
What did FDA cite at Qingdao Kangyuan Pharmaceutical Co., Ltd?
The regulations cited most in the observations on file for Qingdao Kangyuan Pharmaceutical Co., Ltd are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.186 (Master production and control records), 1 time.